Protein array staining methods for undefined protein content, manufacturing quality control, and performance validation

DS Schabacker, I Stefanovska, I Gavin, C Pedrak… - Analytical …, 2006 - Elsevier
DS Schabacker, I Stefanovska, I Gavin, C Pedrak, DP Chandler
Analytical biochemistry, 2006Elsevier
Methods to assess the quality and performance of protein microarrays fabricated from
undefined protein content are required to elucidate slide-to-slide variability and interpolate
resulting signal intensity values after an interaction assay. We therefore developed several
simple total-and posttranslational modification-specific, on-chip staining methods to
quantitatively assess the quality of gel element protein arrays manufactured with whole-cell
lysate in vitro protein fractions derived from two-dimensional liquid-phase fractionation …
Methods to assess the quality and performance of protein microarrays fabricated from undefined protein content are required to elucidate slide-to-slide variability and interpolate resulting signal intensity values after an interaction assay. We therefore developed several simple total- and posttranslational modification-specific, on-chip staining methods to quantitatively assess the quality of gel element protein arrays manufactured with whole-cell lysate in vitro protein fractions derived from two-dimensional liquid-phase fractionation (PF2D) technology. A linear dynamic range of at least 3 logs was observed for protein stains and immobilized protein content, with a lower limit of detection at 8pg of protein per gel element with Deep Purple protein stain and a field-portable microarray imager. Data demonstrate the successful isolation, separation, transfer, and immobilization of putative transmembrane proteins from Yersinia pestis KIM D27 with the combined PF2D and gel element array method. Internal bovine serum albumin standard curves provided a method to assess on-chip PF2D transfer and quantify total protein immobilized per gel element. The basic PF2D array fabrication and quality assurance/quality control methods described here therefore provide a standard operating procedure and basis for developing whole-proteome arrays for interrogating host–pathogen interactions, independent of sequenced genomes, affinity tags, or a priori knowledge of target cell composition.
Elsevier